Mode
Text Size
Log in / Sign up

Intact Fish Skin Graft improves wound area reduction vs standard care in Stage 3-4 pressure ulcersNew Graft Helps Deep Sores Heal Faster Than Standard Care

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider IFSG for pressure ulcers based on improved area reduction, but note healing difference was not significant.

This retrospective matched cohort study analyzed deidentified electronic health record data from the U.S. Wound Registry, including 80 patients with Stage 3-4 pressure ulcers (40 per group). Patients were treated with either Intact Fish Skin Graft (IFSG) or Standard of Care (SOC), with outcomes assessed for percent area reduction (PAR), healed status, and healed or improved rate. Follow-up duration was not reported.

Main results showed IFSG was associated with superior PAR (49% vs 34% for SOC, p=0.0028) and a higher healed or improved rate (67.5% vs 55.0%, p=0.0379). Complete healing occurred in 45.5% of IFSG patients versus 33.3% with SOC, but this difference did not reach statistical significance. Effect sizes and absolute numbers for these outcomes were not reported.

Safety and tolerability data, including adverse events, serious adverse events, and discontinuations, were not reported. Key limitations include a high-risk, real-world cohort with only 37.5% ambulatory patients and a high prevalence of multiple concurrent wounds, which may affect generalizability. Funding and conflicts of interest were not reported.

Practice relevance is that this study supports the use of IFSG as an effective advanced therapy for hard-to-heal pressure ulcers, based on observational evidence. However, the retrospective design and lack of safety data mean results should be interpreted with restraint, and the non-significant difference in complete healing highlights the need for further research to confirm benefits.

Imagine sitting in a chair for hours, feeling a deep, painful sore on your heel that just won't go away. For many people with diabetes or limited mobility, these deep wounds can stay open for months.

These deep pressure ulcers, known as Stage 3 or 4 wounds, are common and very frustrating. They often involve exposed muscle or bone.

Current treatments can take a long time to work. Sometimes, the wound simply does not close up. Patients feel stuck waiting for a solution that might never come.

The Surprising Shift

Doctors usually try standard dressings and skin substitutes first. These methods help some people, but they often fail for the deepest sores.

But here is the twist. A new type of graft made from fish skin is showing better results in real hospitals. It is not a magic cure, but it is helping wounds shrink faster.

Think of a wound like a dry, cracked riverbed. It needs water and life to heal.

Standard dressings cover the wound, but they do not add new cells. The fish skin graft acts like a living patch. It brings fresh cells to the wound site.

It is like bringing a whole team of builders to fix a broken wall instead of just taping the cracks. The graft releases growth factors that tell the body to knit the tissue back together.

Researchers looked at data from the U.S. Wound Registry. They found 40 patients who got the fish skin graft.

They matched these patients with 40 others who got standard care. Both groups had similar ages, health issues, and wound sizes.

The study looked at real-world patients, not just healthy volunteers. This makes the results more trustworthy for everyday use.

The results were clear. More wounds got better with the fish skin graft than with standard care.

Six out of ten patients saw their wound heal or improve significantly. In the standard care group, only five out of ten saw such improvement.

The wound size also shrank much faster. The fish skin group saw a 49% reduction in wound size. The standard care group saw only a 34% reduction.

But there's a catch.

While the numbers look good, not every single patient healed completely. Some wounds still needed more time or different treatments.

Doctors say this fits into a bigger picture of wound care. Advanced therapies are becoming more common for tough cases.

This study adds strong evidence that fish skin is a viable option. It supports using it for patients who struggle with standard methods.

If you or a loved one has a deep sore, talk to your doctor about options. Ask if advanced therapies are right for your specific wound.

This treatment is available now in some clinics. It is not a guaranteed fix, but it offers a new hope for hard-to-heal sores.

More research is needed to confirm these results in larger groups. Scientists will look at long-term outcomes and costs.

Until then, this study gives doctors a powerful new tool. It helps them choose the best path for every patient.

Study Details

Study typeCohort
Sample sizen = 40
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
ObjectiveTo evaluate the real-world effectiveness of Intact Fish Skin Graft (IFSG) compared with standard of care (SOC) in the treatment of Stage 3-4 pressure ulcers, using clinically meaningful outcomes including wound healing rate and percent area reduction (PAR). Materials and MethodsA retrospective matched cohort study was conducted using deidentified electronic health record (EHR) data from the U.S. Wound Registry. Patients with Stage 3-4 pressure ulcers treated with IFSG (n=40) were compared to a matched SOC control group (n=40). 1:1 covariate matching was performed to reduce confounding across key patient and wound characteristics, including age, mobility status, comorbidities (e.g., diabetes, peripheral artery disease), and wound features (age, size, location, and depth). Outcomes included healed status, healed or improved rate, and percent area reduction (PAR). ResultsThe study population represented a high-risk, real-world cohort (n=40 per group), with only 37.5% ambulatory patients and a high prevalence of multiple concurrent wounds. IFSG treatment demonstrated superior clinical outcomes compared to SOC: O_LIHealed or improved: 67.5% (IFSG) vs 55.0% (SOC) (p=0.0379) C_LIO_LIHealed: 45.5% (IFSG) vs 33.3% (SOC) C_LIO_LIPercent area reduction (PAR): 49% (IFSG) vs 34% (SOC) (p=0.0028) C_LI These findings indicate statistically significant improvements in percent area reduction and in the proportion of wounds that were healed or improved with IFSG. The proportion achieving complete healing was numerically higher with IFSG than with SOC, but this difference did not reach statistical significance. ConclusionIn this real-world matched cohort analysis, Intact Fish Skin Graft demonstrated superior effectiveness compared to standard of care in the management of Stage 3-4 pressure ulcers, with improvements in healing-related outcomes and percent area reduction. These results support the use of IFSG as an effective advanced therapy for hard-to-heal pressure ulcers.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.